返回 Agenda
S37 : Recent Phase I Cancer Trial Design and Practice
Session Chair(s)
Takashi Asakawa, PhD
Group Manager, Biometrics Dept.
Chugai Pharmaceuticals Co,.Ltd, Japan
Speaker(s)
Akihiro Hirakawa, PhD
Institute of Science Tokyo, Japan
Professor, Department of Clinical Biostatistics
KENTARO TAKEDA, PhD
Astellas Pharma Global Development, Inc., United States
Head of innovative statistical science
Mie Suzuki, MPH
Pfizer R&D Japan G.K., Japan
Oncology, Clinical Research
Kaito Takahashi
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Joji Mori, PhD
Eli Lilly Japan K.K., Japan
Sr. Advisor, Global Statistical Science Japan